Table 4a.
Characteristics of subjects reporting 0–1 and ≥2 persistent pain conditions
| 0~1 pain conditions | ≥ 2 pain conditions | |
|---|---|---|
| Mean (SD) | Mean (SD) | |
| Age (in years)* | 30.6 (11.2) | 40.5 (12.1) |
| Facial Pain duration from onset (months)* | 39.6 (78.9) | 117.6 (109.7) |
| Average facial pain intensity (past 6-mon)* | 1.7 (2.6) | 4.5 (2.5) |
| Impact due to facial pain (past 6-mon) | ||
| Missed usual activities (days)* | 2.5 (15.6) | 6.1 (16.6) |
| Reduced efficiency to <50% (days)* | 8.8 (48.4) | 17.1 (31.4) |
| Facial pain in the past 1–2 weeks | ||
| 1. Average intensity* | 13.3 (21.9) | 38.7 (26.3) |
| 2. Highest intensity* | 20.9 (31.6) | 54.8 (31.0) |
| 3. Lowest intensity* | 4.9 (12.1) | 17.1 (19.0) |
| 5. % of wake days with pain* | 15.7 (28.6) | 55.1 (35.7) |
| 6. Unpleasantness rating* | 2.7 (4.4) | 8.0 (4.7) |
| Grade chronic pain scale-facial pain (%)* | ||
| GCPS-0 | 65.1 | 12.7 |
| GCPS-I | 16.9 | 33.8 |
| GCPS-II | 15.3 | 42.3 |
| GCPS-III | 0.8 | 7.0 |
| GCPS-IV | 1.9 | 4.2 |
Abbreviations: TMD, temporomandibular disorders; WPT, widespread palpation tenderness; w/o, without; 6-mon, 6 months; GCPS, Grade Chronic Pain Scale.
Note: Number of study subjects included in each group for clinical pain measures:
- 0–1 pain condition group: range 258–265;
- ≥2 pain conditions group: range 71–75.
P<0.004